3T Renal 23Na-MRI: Effects of desmopressin in patients with central diabetes insipidus

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 27, Issue 1, 2014, Pages 47-52

  Haneder, Stefan ^a   Michaely, Henrik J ^a   Konstandin, Simon ^b   Schad, Lothar R ^b   Morelli, John N ^c   Krämer, Bernhard K ^a   Schoenberg, Stefan O ^a   Lammert, Alexander ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

23Na MR imaging; Central diabetes insipidus; Corticomedullary 23Na gradient; DDAVP; Kidney

Indexed keywords

ANTIDIURETIC AGENT; ARGIPRESSIN[1 DEAMINO]; SODIUM;

AGED; ARTICLE; BRAIN; CHEMISTRY; DIABETES INSIPIDUS; HUMAN; INTRANASAL DRUG ADMINISTRATION; KIDNEY; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSPECTIVE STUDY; REPRODUCIBILITY;

ADMINISTRATION, INTRANASAL; AGED; ANTIDIURETIC AGENTS; BRAIN; DEAMINO ARGININE VASOPRESSIN; DIABETES INSIPIDUS; HUMANS; KIDNEY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SODIUM;

EID: 84894044710     PISSN: 09685243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10334-013-0377-4     Document Type: Article

References (35)

1. Di Iorgi N, Napoli F, Allegri AE, Olivieri I, Bertelli E, Gallizia A, Rossi A, Maghnie M (2012) Diabetes insipidus - diagnosis and management. Horm Res Paediatr 77(2):69-84
2. Makaryus AN, McFarlane SI (2006) Diabetes insipidus: diagnosis and treatment of a complex disease. Cleve Clin J Med 73(1):65-71
3. Caldwell HK, Young WSI (2006) Oxytocin and vasopressin: genetics and behavioral implications. In: Lajtha A, Lim R (eds) Handbook of neurochemistry and molecular neurobiology: neuroactive proteins and peptides, 3rd edn. Springer, Berlin, pp 573-607
4. Agarwal SK, Gupta A (2008) Aquaporins: the renal water channels. Indian J Nephrol 18(3):95-100
5. Tomita K, Pisano JJ, Knepper MA (1985) Control of sodium and potassium transport in the cortical collecting duct of the rat. Effects of bradykinin, vasopressin, and deoxycorticosterone. J Clin Invest 76(1):132-136
6. Harris AS (1989) Clinical experience with desmopressin: efficacy and safety in central diabetes insipidus and other conditions. J Pediatr 114(4 Pt 2):711-718
7. Kosman ME (1978) Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP). JAMA 240(17):1896-1897
8. Kapic E, Becic F, Todic M (2005) Modern approach in treatment of diabetes insipidus. Bosn J Basic Med Sci 5(2):38-42
9. Vande Walle J, Stockner M, Raes A, Norgaard JP (2007) Desmopressin 30 years in clinical use: a safety review. Curr Drug Saf 2(3):232-238
10. Kim RJ, Malattia C, Allen M, Moshang T, Maghnie M (2004) Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations. Pediatr Endocrinol Rev 2(Suppl 1):115-123
11. Lam KS, Wat MS, Choi KL, Ip TP, Pang RW, Kumana CR (1996) Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-d-arginine vasopressin in adult patients with central diabetes insipidus. Br J Clin Pharmacol 42(3):379-385
12. Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S, Tinelli C, Gallucci M, Bernasconie S, Boscherini B, Severi F, Arico M (2000) Central diabetes insipidus in children and young adults. N Engl J Med 343(14):998-1007
13. Tisdall M, Crocker M, Watkiss J, Smith M (2006) Disturbances of sodium in critically ill adult neurologic patients: a clinical review. J Neurosurg Anesthesiol 18(1):57-63
14. Sigounas DG, Sharpless JL, Cheng DM, Johnson TG, Senior BA, Ewend MG (2008) Predictors and incidence of central diabetes insipidus after endoscopic pituitary surgery. Neurosurgery 62(1):71-78
15. Argyropoulou MI, Kiortsis DN (2005) MRI of the hypothalamic-pituitary axis in children. Pediatr Radiol 35(11):1045-1055
16. Fujisawa I (2004) Magnetic resonance imaging of the hypothalamic- neurohypophyseal system. J Neuroendocrinol 16(4):297-302
17. Xu X, Fang W, Ling H, Chai W, Chen K (2010) Diffusion-weighted MR imaging of kidneys in patients with chronic kidney disease: initial study. Eur Radiol 20(4):978-983
18. Thoeny HC, Zumstein D, Simon-Zoula S, Eisenberger U, De Keyzer F, Hofmann L, Vock P, Boesch C, Frey FJ, Vermathen P (2006) Functional evaluation of transplanted kidneys with diffusion-weighted and BOLD MR imaging: initial experience. Radiology 241(3):812-821
19. Michaely HJ, Metzger L, Haneder S, Hansmann J, Schoenberg SO, Attenberger UI (2012) Renal BOLD-MRI does not reflect renal function in chronic kidney disease. Kidney Int 81(7):684-689
20. Haneder S, Konstandin S, Morelli JN, Nagel AM, Zoellner FG, Schad LR, Schoenberg SO, Michaely HJ (2011) Quantitative and qualitative 23Na MR imaging of the human kidneys at 3 T: before and after a water load. Radiology 260(3):857-865
21. Maril N, Rosen Y, Reynolds GH, Ivanishev A, Ngo L, Lenkinski RE (2006) Sodium MRI of the human kidney at 3 Tesla. Magn Reson Med 56(6):1229-1234
22. Rosen Y, Lenkinski RE (2009) Sodium MRI of a human transplanted kidney. Acad Radiol 16(7):886-889
23. Haneder S, Michaely HJ, Schoenberg SO, Konstandin S, Schad LR, Siebenlist K, Wertz H, Wenz F, Lohr F, Boda-Heggemann J (2012) Assessment of renal function after conformal radiotherapy and intensity-modulated radiotherapy by functional (1)H-MRI and (23)Na-MRI. Strahlenther Onkol 188(12):1146-1154
24. Lanzman RS, Ljimani A, Pentang G, Zgoura P, Zenginli H, Kröpil P, Heusch P, Schek J, Miese FR, Blondin D, Antoch G, Wittsack HJ (2013) Kidney transplant: functional assessment with diffusion-tensor MR imaging at 3T. Radiology 266(1):218-225
25. Gaudiano C, Clementi V, Busato F, Corcioni B, Orrei MG, Ferramosca E, Fabbri E, Berardi P, Santoro A, Golfieri R (2013) Diffusion tensor imaging and tractography of the kidneys: assessment of chronic parenchymal diseases. Eur Radiol
26. Artz NS, Sadowski EA, Wentland AL, Grist TM, Seo S, Djamali A, Fain SB (2011) Arterial spin labeling MRI for assessment of perfusion in native and transplanted kidneys. Magn Reson Imaging 29(1):74-82
27. Maeda M, Seo Y, Murakami M et al (1990) Sodium-23 MR imaging of the kidney in guinea pig at 2.1 T, following arterial, venous, and ureteral ligation. Magn Reson Med 16(3):361-367
28. Maril N, Margalit R, Rosen S, Heyman SN, Degani H (2006) Detection of evolving acute tubular necrosis with renal 23Na MRI: studies in rats. Kidney Int 69(4):765-768
29. Lanz T, Mayer M, Robson MD, Neubauer S, Ruff J, Weisser A (2007) An 8 channel 23Na heart array for application at 3T. In: Proceedings of the 15th scientific meeting, International society for magnetic resonance in medicine, Berlin, p 247
30. Haneder S, Konstandin S, Morelli JN, Schad LR, Schoenberg SO, Michaely HJ (2013) Assessment of the renal cortico-medullary 23Na-gradient using isotropic data sets. Acad Radiol 20:407-413
31. Maril N, Margalit R, Mispelter J, Degani H (2004) Functional sodium magnetic resonance imaging of the intact rat kidney. Kidney Int 65(3):927-935
32. Maril N, Margalit R, Mispelter J, Degani H (2005) Sodium magnetic resonance imaging of diuresis: spatial and kinetic response. Magn Reson Med 53(3):545-552
33. Lote C (1994) Principles of renal physiology. Chapman & Hall, London
34. Joukhadar C, Schenk B, Kaehler ST, Kollenz CJ, Bauer P, Mueller M, Eichler H-G (2003) A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations. Eur J Clin Pharmacol 59(8-9):631-636
35. Vilhardt H, Lundin S (1986) Biological effect and plasma concentrations of DDAVP after intranasal and peroral administration to humans. Gen Pharmacol 17(4):481-483